Defense Tech: Warhound Secures $200 Million for Gene-Edited Canines

Warhound has raised $200 million in fresh capital to launch a program that will produce genetically modified dogs for the United States military. The funding allows the startup to begin the biological work of editing genes in cell samples taken from a specific cohort of high-performing canines. These donor animals were selected from existing police, military, and first responder units across the country. The group consists primarily of Belgian Malinois, with a smaller number of labradors and shepherds included in the initial pool.

The biological process involves Colossal Biosciences modifying the genetic code of these samples before cloning the animals. The primary scientific focus for this first phase is reducing the likelihood of hereditary health issues. Specifically, the team aims to lower the risk of hip dysplasia and certain cancers that frequently affect these breeds. Ben Lamm of Colossal indicated that future iterations of the program could introduce additional genetic enhancements. These potential upgrades might include improvements to speed, agility, or olfactory sensitivity.

The leadership team brings together two prominent figures in the technology and biotech sectors. Palmer Luckey, who previously founded Oculus VR and established the defense contractor Anduril, is involved in the venture. His company recently won a contract with the US Army to build a next-generation battlefield intelligence system in partnership with Palantir. Lamm, whose Colossal Biosciences is known for de-extinction projects involving the dire wolf and woolly mammoth, provides the biological expertise. The day-to-day operations are led by CEO David Spirk, who most recently worked at Palantir.

The corporate structure separates the technological partners from equity ownership. While Luckey is a partner in the business, neither he nor Anduril holds a financial stake in Warhound. Colossal Biosciences does possess equity in the company, and Lamm serves on the board. Anduril’s role is strictly technological rather than biological. The firm will design the protective equipment and software used by the dogs. This includes items such as goggles, vests, and body armor intended to safeguard the animals during their duties. The project does not currently plan to create cyborg dogs.

The first generation of these engineered canines is expected to be born in early 2027. Once born, the animals will undergo training for standard working dog roles. These include bomb detection and search-and-rescue missions. The timeline places the initial rollout within the next twelve months, aligning the biological milestones with the broader defense technology procurement cycles.

The stakes for this venture lie in creating a more resilient workforce for military operations. By addressing genetic predispositions to injury and disease, the startup aims to extend the operational lifespan of working dogs. The combination of advanced genetics and high-tech protective gear represents a significant shift in how the US military procures non-human assets for the field.